drugset / Trial / NCT00698568
Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects
RandomizedParallel-groupDouble-blindPrevention
Summary
This study will evaluate, versus a placebo, the safety of Herpes simplex candidate vaccine with adjuvant in initially HSV seropositive or seronegative subjects who have no genital herpes disease.
Timeline
- Start
- 1996-10
- Primary completion
- 1999-04
- Completion
- 1999-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK208141 | Vaccine | — | Intramuscular |
Indications
No indication recorded.